Insider trades
Mark Schoenberg, Chief Officer of UroGen Pharma URGN, has filed 0 purchases and 26 sales on the open market. Over the past 12 months that comes to a net sale of $1.2M. The latest trade was on 06/22.
Mark Schoenberg
Chief Medical Officer
- Company
- UroGen Pharma URGN
- First filing
- 23/02/02
- Trades
- 70 trades
- Buys / sales
- 0 / 26
- 12-month net buying
- −$1.2M
- Last trade
- 06/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
UroGen PharmaURGN | Open-market sale10b5-1 plan | 06/22 | 06/24 | 10,000 sh | $35.01 | $350,100 | −7.2% |
UroGen PharmaURGN | Open-market sale | 06/08 | 06/09 | 5,222 sh | $27.30 | $142,560.6 | −3.6% |
UroGen PharmaURGN | Open-market sale10b5-1 plan | 05/08 | 05/11 | 10,000 sh | $30.00 | $300,000 | −6.9% |
| Open-market sale | 02/03 | 02/04 | 7,373 sh3 trades | $19.69avg. | $145,174.37 | −4.8% | |
UroGen PharmaURGN | Open-market sale10b5-1 plan | 25/11/19 | 25/11/20 | 10,000 sh | $25.00 | $250,000 | −6.7% |
UroGen PharmaURGN | Open-market sale | 25/09/08 | 25/09/09 | 871 sh | $19.11 | $16,644.81 | −0.6% |
UroGen PharmaURGN | Open-market sale | 25/08/11 | 25/08/13 | 10,000 sh | $17.69 | $176,900 | −6.3% |
UroGen PharmaURGN | Open-market sale | 25/07/28 | 25/07/30 | 5,149 sh | $19.14 | $98,551.86 | −3.2% |
UroGen PharmaURGN | Open-market sale | 25/06/09 | 25/06/11 | 5,162 sh | $7.37 | $38,043.94 | −3.3% |
| Open-market sale | 25/01/31 | 25/02/04 | 4,551 sh3 trades | $11.14avg. | $50,698.14 | −3.0% | |
UroGen PharmaURGN | Open-market sale | 24/09/09 | 24/09/12 | 859 sh | $13.08 | $11,235.72 | −0.6% |
UroGen PharmaURGN | Open-market sale | 24/06/10 | 24/06/11 | 5,153 sh | $13.08 | $67,401.24 | −3.4% |
UroGen PharmaURGN | Open-market sale | 24/03/18 | 24/03/20 | 12,000 sh | $14.05 | $168,600 | −7.9% |
| Open-market saleAmendment | 24/02/01 | 24/02/05 | 3,789 sh3 trades | $15.78avg. | $59,790.42 | −2.4% | |
| Open-market sale | 24/01/31 | 24/02/02 | 3,789 sh3 trades | $15.74avg. | $59,638.86 | −2.4% | |
| Open-market sale | 23/01/31 | 23/02/02 | 1,900 sh3 trades | $10.12avg. | $19,228 | −1.3% |